← back to database
OrbiMed invests globally across health care, from seed-stage startups to large public companies. Its private-equity strategy backs biopharmaceutical, medical-device, diagnostic, health-care-service, and digital-health companies and typically acts as a lead investor.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
Approximately $20B AUM
Investing team
C. Scotland StevensGeneral Partner
Carl L. GordonManaging Partner
David BonitaGeneral Partner
Geoffrey C. HsuGeneral Partner
Matthew RizzoGeneral Partner
Mona AshiyaGeneral Partner
Peter ThompsonGeneral Partner
- Sven H. BorhoManaging Partner
W. Carter NeildManaging Partner